- EFFICACY AND SAFETY OF CM310 IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2B TRIAL IN CHINAZhang, Jianzhong; Yang, Bin; Li, Jingyi; Ding, Yangfeng; Wu, Liming; Zhang, Litao; Wang, Jinyan; Zhu, Xiaohong; Zhang, Furen; Tao, Xiaohua; Li, Yumei; Zhang, Chunlei; Li, Linfeng; Lu, Jianyun; Diao, Qingchun; Lu, Qianjin; Man, Xiaoyong; Li, Fuqiu; Xia, Xiujuan; Cheng, Hao; Zhao, Yan; Chen, Bo; Yan, Jinchun; Zhao, Guoqing; Jia, Yingmin
- THE COST-EFFECTIVENESS OF BUDESONIDE/ FORMOTEROL MAINTENANCE AND RELIEVER THERAPY VERSUS SALMETEROL/FLUTICASONE PLUS AS-NEEDED SALBUTAMOL AMONG ASTHMA PATIENTS ≥12 YEARS IN CHINAZhou, K.; Xie, X.; Zuo, C.; Jiang, Y.; Xuan, J.
- Interim analysis of a real-world retrospective multicenter study: Evaluation of effectiveness of secukinumab in adult patients with moderate-to-severe plaque psoriasis in ChinaLiu, N.; Xiao, X.; Pan, R.; Li, W.; Yang, B.; Shi, Y.
会议论文
COST-EFFECTIVENESS ANALYSIS OF ABROCITINIB VERSUS DUPILUMAB FOR TREATMENT OF MODERATETO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS
18阅读
